GlaxoSmithKline Agrees To $1 Bln Paxil Settlement - Bloomberg

20th Jul 2010 15:50

LONDON (Dow Jones)--GlaxoSmithKline PLC (GSK) has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects, Bloomberg reports Tuesday citing "people familiar with the settlements." The agreements leave more than 100 cases still pending, the report says. GlaxoSmithKline reports its second-quarter earnings Wednesday. Full story: http://www.bloomberg.com/news/2010-07-20/glaxo-said-to-have-paid-1-billion-to-resolve-paxil-birth-defect-lawsuits.html -London bureau, Dow Jones Newswires; (44) 207 842 9330; [email protected] (END) Dow Jones Newswires July 20, 2010 10:50 ET (14:50 GMT)